Aspects of genetic susceptibility to human infectious diseases

Annual Review of Genetics

Volumn 40, Issue , 2006, Pages 469-486

  Hill, Adrian V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Association; HIV AIDS; Linkage; Malaria; Tuberculosis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHRONIC DISEASE; CHRONIC HEPATITIS; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HEPATITIS B; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LEPROSY; MOUSE STRAIN; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; SIBLING; STREPTOCOCCUS INFECTION; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; COMMUNICABLE DISEASES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HEPATITIS B, CHRONIC; HUMANS; LEPROSY; LINKAGE (GENETICS); MALARIA; MICE; SIGNAL TRANSDUCTION; TUBERCULOSIS;

HEPATITIS B VIRUS; MURINAE;

EID: 33845631591     PISSN: 00664197     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genet.40.110405.090546     Document Type: Review

References (101)

1. Int. HapMap Consortium. 2005. A haplotype map of the human genome. Nature 437:1299-20
2. Abel L, Demenais F. 1988. Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island: Desirade Island. Am. J. Hum. Genet. 42:256-66
3. Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, et al. 2002. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186:1522-25
4. Akira S, Takeda K. 2004. Toll-like receptor signaling. Nat. Rev. Immunol. 4:499-511
5. Allen SJ, O'Donnell A, Alexander ND, Mgone CS, Peto TE, et al. 1999. Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3. Am. J. Trop. Med. Hyg. 60:1056-60
6. Allison AC. 1954. Protection afforded by sickle-cell trait against subtertain malarial infection. Br. Med. J. i:290-94
7. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, et al. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25:187-91
8. Barreiro LB, Neyrolles O, Babb CL, Tailleux L, Quach H, et al. 2006. Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med. 3:e20
9. Barrett JC, Cardon LR. 2006. Evaluating coverage of genome-wide association studies. Nat. Genet. 38:659-62
10. Bayer ME, Blumberg BS, Werner B. 1968. Particles associated with Australia antigen in the sera of patients with leukaemia, Down's syndrome and hepatitis. Nature 218:1057-59
11. Bellamy R. 2005. Genetic susceptibility to tuberculosis. Clin. Chest Med. 26:233-46, vi
12. Bellamy R, Beyers N, McAdam KP, Ruwende C, Gie R, et al. 2000. Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc. Natl. Acad. Sci. USA 97:8005-9
13. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. 1998. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans [see comments]. N. Engl. J. Med. 338:640-44
14. Beutler B, Rietschel ET. 2003. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3:169-76
15. Black RE, Levine MM, Clements ML, Hughes T, O'Donnell S. 1987. Association between O blood group and occurrence and severity of diarrhea due to Escherichia coli. Trans. R. Soc. Trop. Med. Hyg. 81:120-23
16. Blackwell JM, Barton CH, White JK, Roach TI, Shaw MA, et al. 1994. Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Immunol. Lett. 43:99-107
17. Casanova JL, Abel L. 2005. Inborn errors of immunity to infection: the rule rather than the exception. J. Exp. Med. 202:197-201
18. Chapman SJ, Khor CC, Vannberg FO, Maskell NA, Davies CW, et al. 2006. PTPN22 and invasive bacterial disease. Nat. Genet. 38:499-500
19. Chaudhuri A, DasAdhikary CR. 1978. Possible role of blood-group secretory substances in the etiology of cholera. Trans. R. Soc. Trop. Med. Hyg. 72:664-65
20. Child NJ, Yang IA, Pulletz MC, de Courcy-Golder K, Andrews AL, et al. 2003. Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem. Soc. Trans. 31:652-53
21. Comstock GW. 1978. Tuberculosis in twins: a reanalysis of the Prophit survey. Am. Rev. Respir. Dis. 117:621-24
22. Cordell HJ, Clayton DG. 2005. Genetic association studies. Lancet 366:1121-31
23. Creagh EM, O'Neill LA. 2006. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27(8):352-57
24. Diez E, Lee SH, Gauthier S, Yaraghi Z, Tremblay M, et al. 2003. Bircle is the gene within the Lgn1 locus associated with resistance to Legionella pneumophila. Nat. Genet. 33:55-60
25. Dunstan SJ, Hawn TR, Hue NT, Parry CP, Ho VA, et al. 2005. Host susceptibility and clinical outcomes in toll-like receptor 5-deficient patients with typhoid fever in Vietnam. J. Infect. Dis. 191:1068-71
26. Feuk L, Carson AR, Scherer SW. 2006. Structural variation in the human genome. Nat. Rev. Genet. 7:85-97
27. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, et al. 2001. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413:78-83
28. Flint J, Hill AV, Bowden DK, Oppenheimer SJ, Sill PR, et al. 1986. High frequencies of alpha-thalassaemia are the result of natural selection by malaria. Nature 321:744-50
29. Frodsham AJ, Zhang L, Dumpis U, Taib NA, Best S, et al. 2006. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc. Natl. Acad. Sci. USA 103:9148-53
30. Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A. 1994. Dual role of mannan-binding protein in infections: another case of heterosis? Eur. J. Immunogenet. 21:125-31
31. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. 2006. Mannose-binding lectin and its genetic variants. Genes Immun. 7:85-94
32. Genton B, al Yaman F, Mgone CS, Alexander N, Paniu MM, et al. 1995. Ovalocytosis and cerebral malaria [letter]. Nature 378:564-65
33. Gilbert SC, Plebanski M, Gupta S, Morris J, Cox M, et al. 1998. Association of malaria parasite population structure, HLA, and immunological antagonism [see comments]. Science 279:1173-77
34. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, et al. 2005. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 307:1434-40
35. Gutierrez MC, Brisse S, Brosch R, Fahre M, Omais B, et al. 2005. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog. 1:e5
36. Hawn TR, Verbon A, Janer M, Zhao LP, Beutler B, Aderem A. 2005. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. Proc. Natl. Acad. Sci. USA 102:2487-89
37. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, et al. 2003. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease. J. Exp. Med. 198:1563-72
38. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, et al. 1991. Common west African HLA antigens are associated with protection from severe malaria [see comments]. Nature 352:595-600
39. Hill AV, Yates SN, Allsopp CE, Gupta S, Gilbert SC, et al. 1994. Human leukocyte antigens and natural selection by malaria. Philos. Trans. R. Soc. London Ser. B 346:379-85
40. Horiuchi T, Gondo H, Miyagawa H, Otsuka J, Inaba S, et al. 2005. Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT. Genes Immun. 6:162-66
41. Inohara N, Nunez G. 2003. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3:371-82
42. Jabado N, Jankowski A, Dougaparsad S, Picard V, Grinstein S, Gros P. 2000. Natural resistance to intracellular infections. Natural resistance-associated macrophage protein 1 (nramp1) functions as a ph-dependent manganese transporter at the phagosomal membrane. J. Exp. Med. 192:1237-48
43. Jamieson SE, Miller EN, Black GF, Peacock CS, Cordell HJ, et al. 2004. Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun. 5:46-57
44. Kang TJ, Lee SB, Chae GT. 2002. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 20:56-62
45. Kaslow RA, MacNicholl JM, Hill AVS. 2007. Genetic Susceptibility to Infectious Diseases. Oxford: Oxford Univ. Press. In press
46. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-5
47. Kilgus J, Jardetzky T, Gorga JC, Trzeciak A, Gillessen D, Sinigaglia F. 1991. Analysis of the permissive association of a malaria T cell epitope with DR molecules. J. Immunol. 146:307-15
48. Krishnegowda G, Hajjar AM, Zhu J, Douglass EJ, Uematsu S, et al. 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280:8606-16
49. Kronborg G, Garred P. 2002. Mannose-binding lectin genotype as a risk factor for invasive pneumococcal infection. Lancet 360:1176
50. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. 1996. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58:1347-63
51. Kwiatkowski DP. 2005. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77:171-92
52. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, et al. 2006. The PTPN22 C1858T functional polymorphism and autoimmune diseases - a meta-analysis. Rheumatology. Jun 7; [Epub ahead of print]
53. Levine MM, Nalin DR, Rennels MB, Hornick RB, Sotman S, et al. 1979. Genetic susceptibility to cholera. Ann. Hum. Biol. 6:369-74
54. Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, et al. 1989. Hepatitis B virus markers in Chinese twins. Anticancer Res. 9:737-41
55. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, et al. 2003. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9:548-53
56. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, et al. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-77
57. Lorenz E, Mira JP, Frees KL, Schwartz DA. 2002. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 162:1028-32
58. Malhotra D, Darvishi K, Lohra M, Kumar H, Grover C, et al. 2006. Association study of major risk single nucleotide polymorphisms in the common regulatory region of PARK2 and PACRG genes with leprosy in an Indian population. Eur. J. Hum. Genet. 14:438-42
59. Malhotra D, Relhan V, Reddy BS, Bamezai R. 2005. TLR2 Arg677Trp polymorphism in leprosy: revisited. Hum. Genet. 116:413-15
60. Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, et al. 1996. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 14:181-84
61. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31:429-34
62. Martin MP, Lederman MM, Hutcheson HB, Goedert JJ, Nelson GW, et al. 2004. Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J. Virol. 78:14053-56
63. Martinon F, Tschopp J. 2005. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26:447-54
64. Miller LH, Mason SJ, Clyde DF, McGinniss MH. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295:302-4
65. Mira MT, Alcais A, Nguyen VT, Moraes MO, Di Flumeri C, et al. 2004. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427:636-40
66. Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J, et al. 2006. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. Proc. Natl. Acad. Sci. USA 103:177-82
67. Muller-Myhsok B, Stelma FF, Guisse-Sow F, Muntau B, Thye T, et al. 1997. Further evidence suggesting the presence of a locus, on human chromosome 5q31-q33, influencing the intensity of infection with Schistosoma mansoni [letter; comment]. Am. J. Hum. Genet. 61:452-54
68. Neth O, Hann I, Turner MW, Klein NJ. 2001. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 358:614-18
69. North RJ, LaCourse R, Ryan L, Gros P. 1999. Consequence of Nramp1 deletion to Mycobacterium tuberculosis infection in mice. Infect. Immun. 67:5811-14
70. Nyholt DR. 2002. GENEHUNTER: your 'one-stop shop' for statistical genetic analysis? Hum. Hered. 53:2-7
71. O'Brien SJ, Nelson GW. 2004. Human genes that limit AIDS. Nat. Genet. 36:565-74
72. O'Brien TR, Winkler C, Dean M, Nelson JA, Carrington M, et al. 1997. HIV-1 infection in a man homozygous for CCR5 delta 32 [letter] [see comments]. Lancet. 349:1219
73. Ottenhoff TH, Verreck FA, Lichtenauer-Kaligis EG, Hoeve MA, Sanal O, van Dissel JT. 2002. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat. Genet. 32:97-105
74. Pan H, Yan BS, Rojas M, Shebzukhov YV, Zhou H, et al. 2005. Ipr1 gene mediates innate immunity to tuberculosis. Nature 434:767-72
75. Peterslund NA, Koch C, Jensenius JC, Thiel S. 2001. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet. 358:637-38
76. Pritchard JK, Cox NJ. 2002. The allelic architecture of human disease genes: common disease-common variant... or not? Hum. Mol. Genet. 11:2417-23
77. Razmara M, Srinivasula SM, Wang L, Poyet JL, Geddes BJ, et al. 2002. CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis. J. Biol. Chem. 277:13952-58
78. Read RC, Pullin J, Gregory S, Borrow R, Kaczmarski EB, et al. 2001. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J. Infect. Dis. 184:640-42
79. Roy S, Knox K, Segal S, Griffiths D, Moore CE, et al. 2002. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 359:1569-73
80. Sakuntabhai A, Turbpaiboon C, Casademont I, Chuansumrit A, Lowhnoo T, et al. 2005. A variant in the CD209 promoter is associated with severity of dengue disease. Nat. Genet. 37:507-13
81. Siddiqui RM, Meisner S, Tosh K, Balakrishnan K, Ghei S, et al. 2001. A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat. Genet. 27:439-41
82. Skamene E, Gros P, Forget A, Kongshavn PA, St Charles C, Taylor BA. 1982. Genetic regulation of resistance to intracellular pathogens. Nature 297:506-9
83. Smirnova I, Mann N, Dois A, Derkx HH, Hibberd ML, et al. 2003. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc. Natl. Acad. Sci. USA 100:6075-80
84. Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, et al. 2006. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 38:617-19
85. Stockton JC, Howson JM, Awomoyi AA, McAdam KP, Blackwell JM, Newport MJ. 2004. Polymorphism in NOD2, Crohn's disease, and susceptibility to pulmonary tuberculosis. FEMS Immunol. Med. Microbiol. 41:157-60
86. Tang C, Kwiatkowski D. 1999. Mannose-binding lectin and meningococcal disease. Lancet 354:336; author reply p. 337
87. Thorven M, Grahn A, Hedlund KO, Johansson H, Wahlfrid C, et al. 2005. A homozygous nonsense mutation (428G→A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J. Virol. 79:15351-55
88. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. 1995. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia [see comments]. N. Engl. J. Med. 332:1065-69
89. Topol EJ. 2005. Cholesterol, racial variation and targeted medicines. Nat. Med. 11:122-23
90. Tosh K, Campbell SJ, Fielding K, Sillah J, Bah B, et al. 2006. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc. Natl. Acad. Sci. USA 103:10364-68
91. Tosh K, Meisner S, Siddiqui MR, Balakrishnan K, Ghei S, et al. 2002. A region of chromosome 20 is linked to leprosy susceptibility in a South Indian population. J. Infect. Dis. 186:1190-93
92. Tournamille C, Colin Y, Cartron JP, Le Van Kim C. 1995. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10:224-28
93. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. 1993. Natural resistance to infection with intracellular parasites: isolation of a candidate for Beg. Cell 73:469-85
94. Wang WY, Barratt BJ, Clayton DG, Todd JA. 2005. Genome-wide association studies: theoretical and practical concerns. Nat. Rev. Genet. 6:109-18
95. +-thalassemia and the sickle cell trait. Nat. Genet. 37:1253-57
96. Wright EK, Goodart SA, Growney JD, Hadinoto V, Endrizzi MG, et al. 2003. Naip5 affects host susceptibility to the intracellular pathogen Legionella pneumophila. Curr. Biol. 13:27-36
97. Xu J, Zheng SL, Komiya A, Mychaleckyj JC, Isaacs SD, et al. 2003. Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Am. J. Hum. Genet. 72:208-12
98. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, et al. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175:2851-58
99. Young K, Frodsham A, Doumbo OK, Gupta S, Dolo A, et al. 2005. Inverse associations of human leukocyte antigen and malaria parasite types in two West African populations. Infect. Immun. 73:953-55
100. Zamboni DS, Kobayashi KS, Kohlsdorf T, Ogura Y, Long EM, et al. 2006. The Bircle cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat. Immunol. 7:318-25
101. Zeidler M, Stewart G, Cousens SN, Estibeiro K, Will RG. 1997. Codon 129 genotype and new variant CJD [letter; comment]. Lancet 350:668